Trending news

Konstantin Linnik Discusses Amicus Brief that Nutter Filed on Behalf of Biotech Industry Associations in Life Sciences Intellectual Property Review

Print PDF

Konstantin Linnik, Ph.D., a partner in Nutter's Intellectual Property Department and Life Sciences practice group, commented on the amicus brief which the firm filed on behalf of a group of biotech industry associations in the patent case Sequenom v. Ariosa, currently pending petition for review by the U.S. Supreme Court, in Life Sciences Intellectual Property Review. The brief urges the Supreme Court to reconsider the interpretation of patentable subject matter under 35 USC 101 and argues that the current approach hinders investment in the development of new diagnostics and life-saving medicines. In the article, β€œGlobal biotech associations back Sequenom in Ariosa row,” Konstantin, who co-authored the brief, said, β€œThe current U.S. jurisprudence puts the U.S. out of sync with the rest of the industrialised world. It effectively deprives the emerging field of personalised medicine of any intellectual property protection in the U.S., while most other countries are taking a different approach.”

More News >
Back to Page